18.12.2013 • News

Sartorius closes acquisition of TAP Biosystems Group

Sartorius continues to expand its bioprocess business
Sartorius continues to expand its bioprocess business

Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully completed its acquisition of UK company TAP Biosystems Group plc last Monday.  

The cash offer made through Sartorius' wholly owned subsidiary Sartorius Stedim Biotech valued TAP Biosystems Group plc at approximately €33 million and had been approved by TAP Biosystems' shareholders on November 21, 2013.  

The takeover of TAP Biosystems Group plc will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. Founded in 1987, the company is headquartered in Royston, UK, generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.   

 

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Top-Feature

most read